Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants

Journal of Pediatrics

Volumn 138, Issue 3, 2001, Pages 361-365

  Szajewska, Hanna ^a,b,c   Kotowska, Maria ^a,b,c   Mrukowicz, Jacek Z ^a,b,c   Armánska, Malgorzata ^a,b,c   Mikolajczyk, Wieslaw ^a,b,c  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^c Children's Hospital   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PROBIOTIC AGENT;

ARTICLE; CLINICAL TRIAL; COLONY FORMING UNIT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; FEMALE; GASTROENTERITIS; GASTROINTESTINAL INFECTION; HOSPITAL INFECTION; HUMAN; INFANT; LACTOBACILLUS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ROTAVIRUS; TREATMENT OUTCOME; YERSINIA;

EID: 0035096776     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2001.111321     Document Type: Article

References (39)

1. Epidemiology and impact of rotavirus diarrhoea in Poland
2. Impact of rotavirus infection at a large pediatric hospital
3. The incidence of viral-associated diarrhea after admission to a pediatric hospital
4. Use of a prospectively measured incidence rate of nosocomial diarrhea in an infant/toddler ward as a meaningful quality assessment tool
5. Low yield of bacterial stool culture in children with nosocomial diarrhea
6. Yield from stool testing of pediatric inpatients
7. Etiological agents of infectious diarrhea: Implications for requests for microbial culture
8. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus
9. A placebo-controlled trial of Lactobacillus GG to prevent diarrhoea in undernourished Peruvian children
10. Efficacy of Lactobacillus GG as a diarrhoeal preventive in travelers
11. Prevention of traveler's diarrhoea by Lactobacillus GG
12. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children
13. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: A randomized study
14. A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children
15. Oral bacteriotherapy for viral gastroenteritis
16. Viable versus inactivated Lactobacillus strain GG in acute rotavirus diarrhoea
17. A trial in the Karelian Republic of oral rehydration and Lactobacillus GG for treatment of acute diarrhoea
18. Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhea
19. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: A multicenter European study
20. Treatment of recurrent Clotridium difficile colitis with Lactobacillus GG
21. The effect of probiotics on Clostridium difficile diarrhea
22. Passive immunisation of children with bovine colostrum containing antibodies to human rotavirus
23. Small round structured viruses: Airborne transmission and hospital control
24. The incidence of viral-associated diarrhea after admission to a pediatric hospital
25. Nosocomial gastroenteritis in two infant wards over 26 months
26. Human torovirus: A new nosocomial gastrointestinal pathogen
27. Survival of Lactobacillus species (strain GG) in human gastrointestinal tract
28. Antimicrobial substance from a human Lactobacillus strain
29. Role of competition for nutrients in suppression of Clostridium difficile by the colonic microflora
30. Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria
31. Bacterial competition as a means of preventing diarrhoea in pigs
32. Inhibitory activity of Saccharomyces yeasts on the adhesion of Entamoeba histolytica trophozoites to human erythrocytes in vitro
33. Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum
34. Saccharomyces boulardii inhibits secretagogue-mediated adenosine 3′,5′-cyclic monophosphate induction in intestinal cells
35. Enhancement of the circulating antibody secreting cell response in human diarrhoea by a human Lactobacillus strain
36. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis
37. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression
38. Lack of effect of Lactobacillus GG on gastrointestinal bacterial colonisation in premature infants
39. Enteral feeding of premature infants with Lactobacillus GG